Drugs Like Ozempic Shouldn’t Be Prescribed to Children

The world has always focused on appearances. The beauty of the human body and what it should look like in order for it to be admired has shifted over the centuries. Most recently, reaching popularity in the 90s, there has been a growing desire to be thin. With that desire came the production of weight…

Read More

Surgical Robots Are Here to Stay, Despite Lingering Concerns

What used to be routine but complicated medical tasks undertaken by human beings may soon be performed by moving, talking computerized devices. The future has been arriving in the medical field for some time but it seems that the machines are truly getting ready to take over, and that will create medical liability for a…

Read More

The Time for Stricter Drug Regulations Has Come

No matter how much or how little television you watch, it’s impossible to avoid viewing a commercial about a drug that has caused some type of serious disease. The latest news out of the pharmaceutical industry is the recall of ranitidine drugs, the best known of which is Zantac. The recall is just another in…

Read More

Allergan Breast Implant Recall Issued Due to Cancer Risk

CNN reported on July 25, 2019, that Allergan “issued a worldwide recall of Biocell textured breast implants and tissue expanders that have been linked to a rare cancer. The move came after the US Food and Drug Administration requested the manufacturer voluntarily recall the products.” Allergan claimed the recall was in response to global information…

Read More

Women Are Being Over-Prescribed with Opioids After C-Sections

According to a recent study conducted at Vanderbilt University Medical Center and published in the journal Obstetrics and Gynecology, women who undergo Cesarean sections have been routinely overprescribed opioid (narcotic) pain medications. The study looked at 179 patients who had undergone cesareans at VUMC over an eight-week period to examine opioid prescribing practices and consumption…

Read More

Limbrel Capsules Deemed by the FDA as an Unapproved Drug

The Food and Drug Administration (FDA) has suggested that use of the product known as Limbrel may inflict a life-threatening injury to the liver in addition to promoting the development of pancreatitis and hypersensitivity pneumonitis. In November 2017, the FDA issued a warning concerning Limbrel, which Primus Pharmaceuticals, the company that markets the product, designates…

Read More